SKHHY (SKHHY) Stock Price & Analysis
SKHHY (SKHHY) rose 3.63% to USD 14.86 as of July 25, 2026 at 05:33 UTC, according to Nexqual real-time market data.
SKHHY last closed at USD 14.34; the session ranged USD 14.77–15.05 on volume of 10,676 shares. Market capitalization is $7.47B, with a 52-week range of USD 12.94–19.25 (PNK). Source: Nexqual, July 25, 2026 at 05:33 UTC.
Key Statistics (as of July 25, 2026 at 05:33 UTC)
| Price | USD 14.86 |
|---|---|
| Change | ▲ 3.63% (up) |
| Previous Close | USD 14.34 |
| Open | USD 14.83 |
| Day Range | USD 14.77 – 15.05 |
| 52-Week Range | USD 12.94 – 19.25 |
| Volume | 10,676 shares |
| Market Cap | $7.47B |
| Exchange | PNK |
Technical Analysis (SKHHY)
Nexqual's technical model rates SKHHY "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 05:33 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.28 (neutral) |
| vs SMA50 | Above (USD 14.12) |
| MACD | 0.18 (positive) |
Analyst Ratings (SKHHY)
Wall Street analysts rate SKHHY "None", per Nexqual as of July 25, 2026 at 05:33 UTC.
| Consensus Rating | None |
|---|
Earnings (SKHHY)
Source: Nexqual, July 25, 2026 at 05:33 UTC.
Financials & Fundamentals (SKHHY)
| Total Revenue | $10.42B |
|---|---|
| Revenue Growth (YoY) | +16.60% |
| Gross Margin | +32.84% |
| Operating Margin | +8.98% |
| Profit Margin | +5.18% |
| ROE | +6.63% |
| Debt / Equity | 68.22 |
| Current Ratio | 1.01 |
| Total Cash | $557.12M |
| Total Debt | $5.95B |
| Free Cash Flow | $597.78M |
Source: Nexqual, July 25, 2026 at 05:33 UTC.
Financial Health Score (SKHHY)
Nexqual rates SKHHY's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 05:33 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 9% |
| Balance Sheet | Solid — $557M cash vs $5.95B debt |
| Cash Flow | Solid — FCF $598M, 6% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.8% |
Ownership (SKHHY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 494.24M |
| Float | 458.20M |
Source: Nexqual, July 25, 2026 at 05:33 UTC.
Leadership (SKHHY)
SKHHY is led by James Pacey Newcombe, MD, CEO & Executive Director, per Nexqual as of July 25, 2026 at 05:33 UTC.
| MD, CEO & Executive Director | James Pacey Newcombe |
|---|---|
| Finance Director, CFO & Executive Director | Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. (age 67) |
| Group Chief Operating Officer | Evangelos Kotsopoulos |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SSMXY | Sysmex Corp. | USD 9.29 | ▼ 1.9% |
| SKHCF | Sonic Healthcare Ltd. | USD 13.8 | ▲ 0% |
| SAUHY | Straumann Holding AG | USD 11.64 | ▼ 1.61% |
| CHEOY | CochLear Ltd. | USD 39.04 | ▲ 0.03% |
| NNGRY | NN Group NV | USD 45.43 | ▼ 0.46% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:33 UTC. This page is informational and not investment advice.